Time Is Money: Optimizing the Scheduling of Nivolumab

Title
Time Is Money: Optimizing the Scheduling of Nivolumab
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL ONCOLOGY
Volume -, Issue -, Pages JCO.18.00045
Publisher
American Society of Clinical Oncology (ASCO)
Online
2018-08-28
DOI
10.1200/jco.18.00045

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started